Agilent gets EU approval for ovarian cancer companion diagnostic
Go back to Agilent gets EU approval for ovarian cancer companion diagnostic| Agilent Technologies Inc (NYSE: A) | Delayed: 147.13 -3.73 (2.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.86 | 52 Week High | $48.63 | |||
| Open | $148.02 | 52 Week Low | $34.15 | |||
| Day High | $149.22 | P/E | 68.12 | |||
| Day Low | $145.97 | EPS | $2.16 | |||
| Volume | 421,224 | |||||

